Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Understanding pyoderma gangrenosum: a review.

N Wines1, M Wines, W Ryman

  • 1Department of Dermatology, Royal North Shore Hospital, Leonards, Sydney, NSW, Australia. ninahocart@hotmail.com

Medgenmed : Medscape General Medicine
|September 11, 2001
PubMed
Summary

Pyoderma gangrenosum (PG) diagnosis and management require a multidisciplinary approach. Treatment is tailored to severity, with cyclosporine favored for severe cases, though long-term outcomes remain unknown.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pancreatic trauma in children.

Journal of pediatric surgery·2003
Same author

Hippocampus-dependent learning and memory is impaired in mice lacking the Ras-guanine-nucleotide releasing factor 1 (Ras-GRF1).

Neuropharmacology·2001
Same author

Menopause and the skin.

The Australasian journal of dermatology·2001
Same author

Retrospective review of reconstructive methods of conchal bowl defects following mohs micrographic surgery.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2001
Same author

Giant congenital melanocytic naevus and symptomatic thoracic arachnoid cyst.

The Australasian journal of dermatology·2001
Same author

Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection.

Infection and immunity·1998

Area of Science:

  • Dermatology
  • Immunology
  • Internal Medicine

Background:

  • Pyoderma gangrenosum (PG) is a chronic, ulcerative, inflammatory skin disease.
  • Often associated with systemic conditions, requiring a multidisciplinary approach.
  • Limited evidence exists due to a lack of large-scale controlled trials.

Purpose of the Study:

  • To review current understanding of pyoderma gangrenosum diagnosis.
  • To summarize current management strategies for pyoderma gangrenosum.

Main Methods:

  • Critical review of 286 English-language human studies.
  • MEDLINE search from 1960-2000.

Main Results:

  • Diagnosis frequently necessitates input from multiple medical specialists.

Related Experiment Videos

  • Treatment is individualized based on disease severity and comorbidities.
  • Local treatment suffices for mild cases; immunosuppressants like cyclosporine are for severe/refractory disease.

    • Conclusions:

    • Pyoderma gangrenosum management is complex and requires specialist collaboration.
    • Cyclosporine is a preferred immunosuppressant for severe or refractory pyoderma gangrenosum.
    • Long-term patient outcomes for pyoderma gangrenosum are not well-established.